中国心脏起搏与心电生理杂志

参考文献

1 Lloyd-Jones DM,Wang TJ,Leip EP,et al.Lifetime risk for development of atrial fibrillation:the Framingham Heart Study[J].Circulation,2004,110(9):1 042

2 Chugh SS,Havmoeller R,Narayanan K,et al.Worldwide epidemiology of atrial fibrillation:a Global Burden of Disease 2010 Study[J].Circulation,2014,129(8):837

3 Schnabel RB,Yin X,Gona P,et al.50 year trends in atrial fibrillation prevalence,incidence,risk factors,and mortality in the Framingham Heart Study:a cohort study[J].Lancet,2015,386(9989):154

4 Dewland TA,Olgin JE,Vittinghoff E,et al.Incident atrial fibrillation among Asians,Hispanics,blacks,and whites[J].Circulation,2013,128(23):2 470

5 Zhou Z,Hu D.An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of China's mainland[J].J Epidemiol,2008,18(5):209

6 Zhang S.Atrial fibrillation in China's mainland:epidemiology and current management[J].Heart,2009,95(13):1 052

7 Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS[J].Rev Esp Cardiol(Engl Ed),2017,70(1):50

8 Wolowacz SE,Samuel M,Brennan VK,et al.The cost of illness of atrial fibrillation:a systematic review of the recent literature[J].Europace,2011,13(10):1 375

9 Chiang CE,Okumura K,Zhang S,et al.2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation[J].J Arrhythm,2017,33(4):345

10 Bekwelem W,Connolly SJ,Halperin JL,et al.Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation:incidence,risk factors,and outcomes[J].Circulation,2015,132(9):796

11 Staerk L,Sherer J A,Ko D,et al.Atrial fibrillation:epidemiology,pathophysiology,and clinical outcomes[J].Circ Res,2017,120(9):1 501

12 Morin DP,Bernard ML,Madias C,et al.The state of the art:atrial fibrillation epidemiology,prevention,and treatment[J].Mayo Clin Proc,2016,91(12):1 778

13 Soliman EZ,Safford MM,Muntner P,et al.Atrial fibrillation and the risk of myocardial infarction[J].JAMA Intern Med,2014,174(1):107

14 Violi F,Soliman EZ,P ignatelli P,et al.Atrial fibrillation and myocardial infarction:a systematic review and appraisal of pathophysiologic mechanisms[J].J Am Heart Assoc,2016,5(5).

15 Knecht S,Oelschlager C,Duning T,et al.Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy[J].Eur Heart J,2008,29(17):2 125

16 Bohm M,Ezekowitz MD,Connolly SJ,et al.Changes in Renal Function in Patients With Atrial Fibrillation:An Analysis From the RE-LY Trial[J].J Am Coll Cardiol,2015,65(23):2 481

17 Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J].Europace,2016,18(11):1 609

18 January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J].Circulation,2014,130(23):e199

19 Haissaguerre M,Jais P,Shah DC,et al.Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J].N Engl J Med,1998,339(10):659

20 Liu J,Huang CX,Bao MW,et al.Ectopic activity induced by elevated atrial pressure in rabbit pulmonary vein in vitro[J].Chin Med J(Engl),2005,118(14):1 210

21 王晞,黄从新,王腾.兔肺静脉肌袖心肌细胞动作电位和钾、钙离子流特性的研究[J].中华心血管病杂志,2002(04):43

22 王晞,黄从新,江洪,等.兔肺静脉心肌袖组织学特性研究[J].中华心律失常学杂志,2003(04):49

23 谢双伦,黄从新,江洪,等.兔上下腔静脉中的心肌细胞组织结构研究[J].中华心律失常学杂志,2003(04):42

24 杨延宗,黄从新,高连君,等.阵发性心房颤动大静脉电隔离后肌袖内自发电活动的特点[J].中华心律失常学杂志,2004(03):18

25 江洪,黄从新,唐其柱,等.肺静脉异常电活动引起持续性心房颤动的电生理特点和消融治疗[J].中华心血管病杂志,2004(03):22

26 Moe GK,Abildskov JA.Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge[J].Am Heart J,1959,58(1):59

27 Mandapati R,Skanes A,Chen J,et al.Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart[J].Circulation,2000,101(2):194

28 Pandit SV,Jalife J.Rotors and the dynamics of cardiac fibrillation[J].Circ Res,2013,112(5):849

29 Narayan SM,Krummen DE,Shivkumar K,et al.Treatment of atrial fibrillation by the ablation of localized sources:CONFIRM(Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)trial[J].J Am Coll Cardiol,2012,60(7):628

30江洪.心房颤动发病机制研究十年回顾[Z].中国浙江杭州:20084

31 Iwasaki YK,Nishida K,Kato T,et al.Atrial fibrillation pathophysiology:implications for management[J].Circulation,2011,124(20):2 264

32 Shen MJ,Zipes DP.Role of the autonomic nervous system in modulating cardiac arrhythmias[J].Circ Res,2014,114(6):1004

33 Zhou J,Scherlag BJ,Edwards J,et al.Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi[J].J Cardiovasc Electrophysiol,2007,18(1):83

34 Katritsis DG,Pokushalov E,Romanov A,et al.Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation:a randomized clinical trial[J].J Am Coll Cardiol,2013,62(24):2 318

35 Lubitz SA,Yin X,Fontes JD,et al.Association between familial atrial fibrillation and risk of new-onset atrial fibrillation[J].JAMA,2010,304(20):2 263

36 Christophersen IE,Ellinor PT.Genetics of atrial fibrillation:from families to genomes[J].J Hum Genet,2016,61(1):61

37 Goette A,Staack T,Rocken C,et al.Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation[J].J Am Coll Cardiol,2000,35(6):1 669

38 Iravanian S,Dudley SJ.The renin-angiotensin-aldosterone system(RAAS)and cardiac arrhythmias[J].Heart Rhythm,2008,5(6Suppl):S12

39 Frustaci A,Chimenti C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation[J].Circulation,1997,96(4):1 180

40 Wynn GJ,Todd DM,Webber M,et al.The European Heart Rhythm Association symptom classification for atrial fibrillation:validation and improvement through a simple modification[J].Europace,2014,16(7):965

41 Kumarathurai P,Mouridsen MR,Mattsson N,et al.Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation:a population-based cohort study[J].Europace,2017,19(3):364

42 Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J].Eur Heart J,2016,37(38):2 893

43 Kuwahara T.Intracardiac echocardiography in catheter ablation for atrial fibrillation:it is better to see what you are doing[J]?J Atr Fibrillation,2015,7(6):1 215

44 Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J].Eur Heart J,2010,31(19):2 369

45 Marrouche NF,Wilber D,Hindricks G,et al.Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation:the DECAAF study[J].JAMA,2014,311(5):498

46 Kirchhof P,Bax J,Blomstrom-Lundquist C,et al.Early and comprehensive management of atrial fibrillation:executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference'research perspectives in AF'[J].Eur Heart J,2009,30(24):2 969

47 Gladstone DJ,Spring M,Dorian P,et al.Atrial fibrillation in patients with cryptogenic stroke[J].N Engl J Med,2014,370(26):2467

48 Calkins H,Hindricks G,Cappato R,et al.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J].Heart Rhythm,2017,14 (10):e275

49 Quinn FR,Gladstone D.Screening for undiagnosed atrial fibrillation in the community[J].Curr Opin Cardiol,2014,29(1):28

50 Calkins H,Hindricks G,Cappato R,et al.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation:executive summary[J].J Interv Card Electrophysiol,2017,50(1):1

51 黄从新,张澍,黄德嘉,等.心房颤动:目前的认识和治疗建议-2015[J].中国心脏起搏与心电生理杂志,2015,29(05):377

52 Huxley RR,Lopez FL,Folsom AR,et al.Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors:the Atherosclerosis Risk in Communities(ARIC)study[J].Circulation,2011,123(14):1 501

53 Thomas MC,Dublin S,Kaplan RC,et al.Blood pressure control and risk of incident atrial fibrillation[J].Am J Hypertens,2008,21(10):1111

54 Grundvold I,Skretteberg PT,Liestol K,et al.Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men:a 35-year follow-up study[J].Hypertension,2012,59(2):198

55 Conen D,Tedrow UB,Koplan BA,et al.Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women[J].Circulation,2009,119(16):2 146

56 Kistler PM,Sanders P,Dodic M,et al.Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure:implications for development of atrial fibrillation[J].Eur Heart J,2006,27(24):3 045

57 Wokhlu A,Hodge DO,Monahan KH,et al.Long-term outcome of atrial fibrillation ablation:impact and predictors of very late recurrence[J].J Cardiovasc Electrophysiol,2010,21(10):1 071

58 Marott SC,Nielsen SF,Benn M,et al.Antihypertensive treatment and risk of atrial fibrillation:a nationwide study[J].Eur Heart J,2014,35(18):1 205

59 Healey JS,Baranchuk A,Crystal E,et al.Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers:a meta-analysis[J].J Am Coll Cardiol,2005,45(11):1 832

60 Kato T,Yamashita T,Sekiguchi A,et al.What are arrhythmogenic substrates in diabetic rat atria[J]?J Cardiovasc Electrophysiol,2006,17(8):890

61 Fatemi O,Yuriditsky E,Tsioufis C,et al.Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus(from the Action to Control Cardiovascular Risk in Diabetes Study)[J].Am J Cardiol,2014,114(8):1 217

62 Lin KJ,Cho SI,Tiwari N,et al.Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation:systematic review and meta-analysis[J].J Interv Card Electrophysiol,2014,39(3):211

63 Chang SH,Wu LS,Chiou MJ,et al.Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus:a population-based dynamic cohort and in vitro studies[J].Cardiovasc Diabetol,2014,13:123

64 Nguyen TN,Hilmer SN,Cumming RG.Review of epidemiology and management of atrial fibrillation in developing countries[J].Int J Cardiol,2013,167(6):2 412

65 Ector J,Dragusin O,Adriaenssens B,et al.Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation[J].J Am Coll Cardiol,2007,50(3):234

66 Shoemaker MB,Muhammad R,Farrell M,et al.Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation[J].Am J Cardiol,2013,111(3):368

67 Pathak RK,Middeldorp ME,Meredith M,et al.Long-term effect of goal-directed weight management in an atrial fibrillation cohort:a long-term follow-up study(LEGACY)[J].J Am Coll Cardiol,2015,65(20):2 159

68 Holmqvist F,Guan N,Zhu Z,et al.Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation(ORBIT-AF)[J].Am Heart J,2015,169(5):647

69 Patel D,Mohanty P,Di Biase L,et al.Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea:the impact of continuous positive airway pressure[J].Circ Arrhythm Electrophysiol,2010,3(5):445

70 Li L,Wang ZW,Li J,et al.Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment:a meta-analysis of observational studies[J].Europace,2014,16(9):1 309

71 Larsson SC,Drca N,Wolk A.Alcohol consumption and risk of atrial fibrillation:a prospective study and dose-response meta-analysis[J].J Am Coll Cardiol,2014,64(3):281

72 Pathak RK,Middeldorp ME,Lau DH,et al.Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation:the ARREST-AF cohort study[J].J Am Coll Cardiol,2014,64(21):2 222

73 Wilber DJ.Fibroblasts,focal triggers,and persistent atrial fibrillation:Is there a connection[J]?Circ Arrhythm Electrophysiol,2012,5(2):249

74 Qureshi WT,Alirhayim Z,Blaha MJ,et al.Cardiorespiratory fitness and risk of incident atrial fibrillation:results from the henry ford exercise testing(FIT)project[J].Circulation,2015,131(21):1 827

75 Malmo V,Nes BM,Amundsen BH,et al.Aerobic Interval Training Reduces the Burden of Atrial Fibrillation in the Short Term:A Randomized Trial[J].Circulation,2016,133(5):466

76 Abdulla J,Nielsen JR.Is the risk of atrial fibrillation higher in athletes than in the general population?A systematic review and metaanalysis[J].Europace,2009,11(9):1 156

77 Heidbuchel H,Anne W,Willems R,et al.Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter[J].Int J Cardiol,2006,107(1):67

78 Pelliccia A,Culasso F,Di Paolo FM,et al.Physiologic left ventricular cavity dilatation in elite athletes[J].Ann Intern Med,1999,130(1):23

79 Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:the Framingham Study[J].Stroke,1991,22(8):983

80 Wattigney WA,Mensah GA,Croft JB.Increasing trends in hospitalization for atrial fibrillation in the United States,1985 through1999:implications for primary prevention[J].Circulation,2003,108(6):711

81 Lin HJ,Wolf P A,Kelly-Hayes M,et al.Stroke severity in atrial fibrillation.The Framingham Study[J].Stroke,1996,27(10):1760

82 Hart RG,Pearce LA,Aguilar MI.Meta-analysis:antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J].Ann Intern Med,2007,146(12):857

83 January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol,2014,64(21):e1

84 Giugliano RP,Ruff CT,Braunwald E,et al.Edoxaban versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2013,369(22):2 093

85 Patel MR,Mahaffey KW,Garg J,et al.Rivaroxaban versus warfarin in nonvalvular atrial fibrillation[J].N Engl J Med,2011,365(10):883

86 Granger CB,Alexander JH,Mcmurray JJ,et al.Apixaban versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2011,365(11):981

87 Connolly SJ,Ezekowitz MD,Yusuf S,et al.Dabigatran versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2009,361(12):1 139

88 Flegel KM,Shipley MJ,Rose G.Risk of stroke in non-rheumatic atrial fibrillation[J].Lancet,1987,1(8532):526

89 Chien KL,Su TC,Hsu HC,et al.Atrial fibrillation prevalence,incidence and risk of stroke and all-cause death among Chinese[J].Int J Cardiol,2010,139(2):173

90 Li L H,Sheng CS,Hu BC,et al.The prevalence,incidence,management and risks of atrial fibrillation in an elderly Chinese population:a prospective study[J].BMC Cardiovasc Disord,2015,15:31

91 Friberg L,Rosenqvist M,Lindgren A,et al.High prevalence of atrial fibrillation among patients with ischemic stroke[J].Stroke,2014,45(9):2 599

92 Maron BJ,Olivotto I,Bellone P,et al.Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy[J].J Am Coll Cardiol,2002,39(2):301

93 Olivotto I,Cecchi F,Casey SA,et al.Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy[J].Circulation,2001,104(21):2 517

94 Zabalgoitia M,Halperin JL,Pearce LA,et al.Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation.Stroke Prevention in Atrial FibrillationⅢInvestigators[J].J Am Coll Cardiol,1998,31(7):1 622

95 Klein AL,Grimm RA,Murray RD,et al.Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation[J].N Engl J Med,2001,344(19):1 411

96 Gage BF,Waterman AD,Shannon W,et al.Validation of clinical classification schemes for predicting stroke:results from the National Registry of Atrial Fibrillation[J].JAMA,2001,285(22):2 864

97 Lip GY,Nieuwlaat R,Pisters R,et al.Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach:the euro heart survey on atrial fibrillation[J].Chest,2010,137(2):263

98 Laupacis A,Boysen G,Connolly S,et al.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.Analysis of pooled data from five randomized controlled trials[J].Arch Intern Med,1994,154(13):1 449

99 Moulton AW,Singer DE,Haas JS.Risk factors for stroke in patients with nonrheumatic atrial fibrillation:a case-control study[J].Am J Med,1991,91(2):156

100 Guo Y,Apostolakis S,Blann AD,et al.Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation[J].Int J Cardiol,2013,168(2):904

101 Lip GY,Frison L,Halperin JL,et al.Identifying patients at high risk for stroke despite anticoagulation:a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort[J].Stroke,2010,41(12):2 731

102 Chao TF,Liu CJ,Wang KL,et al.Using the CHA2DS2-VASc score for refining stroke risk stratification in'low-risk'Asian patients with atrial fibrillation[J].J Am Coll Cardiol,2014,64(16):1 658

103 Ruff CT,Giugliano RP,Braunwald E,et al.Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation:a meta-analysis of randomised trials[J].Lancet,2014,383(9921):955

104 Lip GY,Al-Khatib SM,Cosio FG,et al.Contemporary management of atrial fibrillation:what can clinical registries tell us about stroke prevention and current therapeutic approaches[J]?J Am Heart Assoc,2014,3(4):e1 179

105 Gorst-Rasmussen A,Skjoth F,Larsen TB,et al.Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis:a nationwide cohort study[J].J Thromb Haemost,2015,13(4):495

106 Lip GY,Skjoth F,Rasmussen LH,et al.Oral anticoagulation,aspirin,or no therapy in patients with nonvalvular AF with 0 or 1stroke risk factor based on the CHA2DS2-VASc score[J].J Am Coll Cardiol,2015,65(14):1 385

107 Fauchier L,Lecoq C,Clementy N,et al.Oral anticoagulation and the risk of stroke or death in patients with atrial fibrillation and one additional stroke risk factor:the loire valley atrial fibrillation project[J].Chest,2016,149(4):960

108 Joundi RA,Cipriano LE,Sposato LA,et al.Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2-VASc Score of 1:systematic review and meta-analysis[J].Stroke,2016,47(5):1364

109 Olesen JB,Lip GY,Lindhardsen J,et al.Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation:A net clinical benefit analysis using a'real world'nationwide cohort study[J].Thromb Haemost,2011,106(4):739

110 Chao TF,Liu CJ,Wang KL,et al.Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score(beyond sex)receive oral anticoagulation[J]?J Am Coll Cardiol,2015,65(7):635

111 Mikkelsen AP,Lindhardsen J,Lip GY,et al.Female sex as a risk factor for stroke in atrial fibrillation:a nationwide cohort study[J].J Thromb Haemost,2012,10(9):1 745

112 Wagstaff AJ,Overvad TF,Lip GY,et al.Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation?A systematic review and meta-analysis[J].QJM,2014,107(12):955

113 Hart RG,Pearce LA,Rothbart R M,et al.Stroke with intermittent atrial fibrillation:incidence and predictors during aspirin therapy.Stroke Prevention in Atrial Fibrillation Investigators[J].J Am Coll Cardiol,2000,35(1):183

114 Pisters R,Lane DA,Nieuwlaat R,et al.A novel user-friendly score(HAS-BLED)to assess 1-year risk of major bleeding in patients with atrial fibrillation:the Euro Heart Survey[J].Chest,2010,138(5):1 093

115 Lip GY,Frison L,Halperin JL,et al.Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation:the HAS-BLED(Hypertension,Abnormal Renal/Liver Function,Stroke,Bleeding History or Predisposition,Labile INR,Elderly,Drugs/Alcohol Concomitantly)score[J].J Am Coll Cardiol,2011,57(2):173

116 Miller VT,Rothrock JF,Pearce LA,et al.Ischemic stroke in patients with atrial fibrillation:effect of aspirin according to stroke mechanism.Stroke Prevention in Atrial Fibrillation Investigators[J].Neurology,1993,43(1):32

117 Mcbride R,Chesebro JH,Wiebers DO,et al.Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation:Stroke Prevention in Atrial FibrillationⅡStudy[J].Lancet,1994,8899(343):687

118 Connolly S,Pogue J,Hart R,et al.Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events(ACTIVE W):a randomised controlled trial[J].Lancet,2006,367(9526):1 903

119 Connolly SJ,Pogue J,Hart RG,et al.Effect of clopidogrel added to aspirin in patients with atrial fibrillation[J].N Engl J Med,2009,360(20):2 066

120 Connolly SJ,Eikelboom J,Joyner C,et al.Apixaban in patients with atrial fibrillation[J].N Engl J Med,2011,364(9):806

121 Mant J,Hobbs FD,Fletcher K,et al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation(the Birmingham Atrial Fibrillation Treatment of the Aged Study,BAFTA):a randomised controlled trial[J].Lancet,2007,370(9586):493

122 Gallagher AM,Setakis E,P lumb JM,et al.Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients[J].Thromb Haemost,2 0 1 1,1 0 6(5):968

123 Apostolakis S,Sullivan RM,Olshansky B,et al.Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin:the SAMe-TT(2)R(2)score[J].Chest,2013,144(5):1 555

124 Lip G,Haguenoer K,Saint-Etienne C,et al.Relationship of the SAMe-TT(2)R(2)score to poor-quality anticoagulation,stroke,clinically relevant bleeding,and mortality in patients with atrial fibrillation[J].Chest,2014,146(3):719

125 Gallego P,Roldan V,Marin F,et al.SAMe-TT2 R2 score,time in therapeutic range,and outcomes in anticoagulated patients with atrial fibrillation[J].Am J Med,2014,127(11):1083

126 Chan PH,Hai JJ,Chan EW,et al.Use of the SAMe-TT2R2 score to predict good anticoagulation control with warfarin in Chinese patients with atrial fibrillation:relationship to ischemic stroke incidence[J].PLo S One,2016,11(3):e150674

127 Van Spall HG,Wallentin L,Yusuf S,et al.Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries:an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy(RE-LY)trial[J].Circulation,2012,126(19):2 309

128 Limdi NA,Veenstra DL.Warfarin pharmacogenetics[J].Pharmacotherapy,2008,28(9):1 084

129 Legrand M,Mateo J,Aribaud A,et al.The use of dabigatran in elderly patients[J].Arch Intern Med,2011,171(14):1 285

130 Fox KA,Piccini JP,Wojdyla D,et al.Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment[J].Eur Heart J,2011,32(19):2 387

131 Eikelboom JW,Connolly SJ,Brueckmann M,et al.Dabigatran versus warfarin in patients with mechanical heart valves[J].N Engl J Med,2013,369(13):1 206

132 Heidbuchel H,Verhamme P,Alings M,et al.Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation[J].Europace,2015,17(10):1 467

133 Hori M,Connolly SJ,Zhu J,et al.Dabigatran versus warfarin:effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation[J].Stroke,2013,44(7):1891

134 Wong KS,Hu DY,Oomman A,et al.Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial[J].Stroke,2014,45(6):1 739

135 Goto S,Zhu J,Liu L,et al.Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia:a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation(ARISTOTLE)Trial[J].Am Heart J,2014,168(3):303

136 Yamashita T,Koretsune Y,Yang Y,et al.Edoxaban vs.warfarin in East Asian patients with atrial fibrillation-an ENGAGE AF-TIMI48 subanalysis[J].Circ J,2016,80(4):860

137 Lip GY,Wang KL,Chiang CE.Non-vitamin K antagonist oral anticoagulants(NOACs)for stroke prevention in Asian patients with atrial fibrillation:time for a reappraisal[J].Int J Cardiol,2015,180:246

138 Shen AY,Yao JF,Brar SS,et al.Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation[J].J Am Coll Cardiol,2007,50(4):309

139 Wang KL,Lip GY,Lin SJ,et al.Non-vitamin K antagonist oral anticoagulants for stroke prevention in asian patients with nonvalvular atrial fibrillation:meta-analysis[J].Stroke,2015,46(9):2555

140 Group J.Guidelines for pharmacotherapy of atrial fibrillation(JCS2008):digest version[J].Circ J,2010,74(11):2 479

141 Lip GY,Huber K,Andreotti F,et al.Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting:executive summary——a Consensus Document of the European Society of Cardiology Working Group on Thrombosis,endorsed by the European Heart Rhythm Association(EHRA)and the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur Heart J,2010,31(11):1 311

142 Lamberts M,Gislason GH,Lip GY,et al.Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant:a nationwide cohort study[J].Circulation,2014,129(15):1 577

143 Dewilde WJ,Oirbans T,Verheugt FW,et al.Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention:an open-label,randomised,controlled trial[J].Lancet,2013,381(9872):1 107

144 Gibson CM,Mehran R,Bode C,et al.Prevention of bleeding in patients with atrial fibrillation undergoing PCI[J].N Engl J Med,2016,375(25):2 423

145 Cavallari I,Patti G.Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention[J].Am J Cardiol,2018,121(6):718

146 Nielsen PB,Larsen TB,Skjoth F,et al.Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke,mortality,and bleeding:a nationwide cohort study[J].Circulation,2015,132(6):517

147 Tomaselli GF,Mahaffey KW,Cuker A,et al.2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants:a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways[J].J Am Coll Cardiol,2017,70(24):3 042

148 Douketis JD,Spyropoulos AC,Kaatz S,et al.Perioperative bridging anticoagulation in patients with atrial fibrillation[J].N Engl J Med,2015,373(9):823

149 Ayoub K,Nairooz R,Almomani A,et al.Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation:Evidence from Meta-analysis[J].J Stroke Cerebrovasc Dis,2016,25(9):2 215

150 Santangeli P,Di Biase L,Horton R,et al.Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications:evidence from a meta-analysis[J].Circ Arrhythm Electrophysiol,2012,5(2):302

151 Calkins H,Willems S,Gerstenfeld EP,et al.Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation[J].N Engl J Med,2017,376(17):1 627

152 Cappato R,Marchlinski FE,Hohnloser SH,et al.Uninterrupted rivaroxaban vs.uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation[J].Eur Heart J,2015,36(28):1 805

153 Lip GY,Lane DA.Bleeding risk assessment in atrial fibrillation:observations on the use and misuse of bleeding risk scores[J].J Thromb Haemost,2016,14(9):1 711

154 Roskell NS,Samuel M,Noack H,et al.Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists:a systematic review of randomized and observational studies[J].Europace,2013,15(6):787

155 van Ryn J,Stangier J,Haertter S,et al.Dabigatran etexilate--a novel,reversible,oral direct thrombin inhibitor:interpretation of coagulation assays and reversal of anticoagulant activity[J].Thromb Haemost,2010,103(6):1 116

156 Pollack CJ,Reilly PA,Bernstein R,et al.Design and rationale for RE-VERSE AD:A phase 3 study of idarucizumab,a specific reversal agent for dabigatran[J].Thromb Haemost,2015,114(1):198

157 Pollack CJ,Reilly PA,van Ryn J,et al.Idarucizumab for dabigatran reversal-full cohort analysis[J].N Engl J Med,2017,377(5):431

158 Reddy VY,Sievert H,Halperin J,et al.Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation:a randomized clinical trial[J].JAMA,2014,312(19):1 988

159 Reddy VY,Doshi SK,Kar S,et al.5-year outcomes after left atrial appendage closure:from the PREVAIL and PROTECT AF Trials[J].J Am Coll Cardiol,2017,70(24):2 964

160 Boersma LV,Schmidt B,Betts TR,et al.Implant success and safety of left atrial appendage closure with the WATCHMAN device:peri-procedural outcomes from the EWOLUTION registry[J].Eur Heart J,2016,37(31):2 465

161 Tzikas A,Shakir S,Gafoor S,et al.Left atrial appendage occlusion for stroke prevention in atrial fibrillation:multicentre experience with the AMPLATZER Cardiac Plug[J].Euro Intervention,2016,11(10):1 170

162 Huang H,Liu Y,Xu Y,et al.Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation:A Prospective,Multicenter Clinical Study[J].JACC Cardiovasc Interv,2017,10(21):2 188

163 Lakkireddy D,Afzal M R,Lee R J,et al.Short and long-term outcomes of percutaneous left atrial appendage suture ligation:Results from a US multicenter evaluation[J].Heart Rhythm,2016,13(5):1 030

164 Chatterjee S,Herrmann HC,Wilensky RL,et al.Safety and procedural success of left atrial appendage exclusion with the lariat device:a systematic review of published reports and analytic review of the FDA MAUDE Database[J].JAMA Intern Med,2015,175(7):1 104

165 Van Gelder IC,Groenveld HF,Crijns HJ,et al.Lenient versus strict rate control in patients with atrial fibrillation[J].N Engl J Med,2010,362(15):1 363

166 Kotecha D,Holmes J,Krum H,et al.Efficacy of beta blockers in patients with heart failure plus atrial fibrillation:an individual-patient data meta-analysis[J].Lancet,2014,384(9961):2235

167 Vamos M,Erath JW,Hohnloser SH.Digoxin-associated mortality:a systematic review and meta-analysis of the literature[J].Eur Heart J,2015,36(28):1 831

168 Gheorghiade M,Fonarow GC,van Veldhuisen DJ,et al.Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin:findings from post hoc propensity-matched analysis of the AFFIRM trial[J].Eur Heart J,2013,34(20):1 489

169 Group DI.The effect of digoxin on mortality and morbidity in patients with heart failure[J].N Engl J Med,1 9 9 7,3 3 6(8):525

170 Wang RX,Lee HC,Hodge DO,et al.Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation[J].Heart Rhythm,2013,10(5):696

171 Ogawa S,Yamashita T,Yamazaki T,et al.Optimal treatment strategy for patients with paroxysmal atrial fibrillation:J-RHYTHM Study[J].Circ J,2009,73(2):242

172 Freudenberger RS,Wilson AC,Kostis JB.Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction(from the AFFIRM Study)[J].Am J Cardiol,2007,100(2):247

173 Hagens VE,Crijns HJ,Van Veldhuisen DJ,et al.Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure:results from the RAte Control versus Electrical cardioversion(RACE)study[J].Am Heart J,2005,149(6):1 106

174 Saksena S,Slee A,Waldo AL,et al.Cardiovascular outcomes in the AFFIRM Trial(Atrial Fibrillation Follow-Up Investigation of Rhythm Management).An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity scorematched analyses[J].J Am Coll Cardiol,2011,58(19):1 975

175 Perez A,Touchette DR,Didomenico RJ,et al.Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure:a cost-effectiveness analysis[J].Pharmacotherapy,2011,31(6):552

176 Talajic M,Khairy P,Levesque S,et al.Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation[J].J Am Coll Cardiol,2010,55(17):1 796

177 Corley SD,Epstein AE,Dimarco JP,et al.Relationships between sinus rhythm,treatment,and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management(AFFIRM)Study[J].Circulation,2004,109(12):1 509

178 Hunter RJ,Berriman TJ,Diab I,et al.A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure(the CAMTAF trial)[J].Circ Arrhythm Electrophysiol,2014,7(1):31

179 Al HS,Qintar M,Hussein A,et al.Catheter ablation for atrial fibrillation in heart failure patients:a meta-analysis of randomized controlled trials[J].JACC Clin Electrophysiol,2015,1(3):200

180 Kirchhof P,Breithardt G,Camm AJ,et al.Improving outcomes in patients with atrial fibrillation:rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial[J].Am Heart J,2013,166(3):442

181 Cheng X,Li X,He Y,et al.Catheter ablation versus anti-arrhythmic drug therapy for the management of a trial fibrillation:a metaanalysis[J].J Interv Card Electrophysiol,2014,41(3):267

182 Potpara TS,Stankovic GR,Beleslin BD,et al.A 12-year followup study of patients with newly diagnosed lone atrial fibrillation:implications of arrhythmia progression on prognosis:the Belgrade Atrial Fibrillation study[J].Chest,2012,141(2):339

183 de Vos CB,Pisters R,Nieuwlaat R,et al.Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis[J].J Am Coll Cardiol,2010,55(8):725

184 Van Gelder IC,Haegeli LM,Brandes A,et al.Rationale and current perspective for early rhythm control therapy in atrial fibrillation[J].Europace,2011,13(11):1 517

185 Chen WS,Gao BR,Chen WQ,et al.Comparison of pharmacological and electrical cardioversion in permanent atrial fibrillation after prosthetic cardiac valve replacement:a prospective randomized trial[J].J Int Med Res,2013,41(4):1 067

186 Gitt AK,Smolka W,Michailov G,et al.Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation:results of the German RHYTHM-AF Study[J].Clin Res Cardiol,2013,102(10):713

187 Al-Khatib SM,Allen LN,Chatterjee R,et al.Rate-and rhythmcontrol therapies in patients with atrial fibrillation:a systematic review[J].Ann Intern Med,2014,160(11):760

188 Kirchhof P,Andresen D,Bosch R,et al.Short-term versus longterm antiarrhythmic drug treatment after cardioversion of atrial fibrillation(Flec-SL):a prospective,randomised,open-label,blinded endpoint assessment trial[J].Lancet,2012,380(9838):238

189 Bash LD,Buono JL,Davies GM,et al.Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation[J].Cardiovasc Drugs Ther,2012,26(2):167

190 Falk RH,Pollak A,Singh SN,et al.Intravenous dofetilide,a classⅢantiarrhythmic agent,for the termination of sustained atrial fibrillation or flutter.Intravenous Dofetilide Investigators[J].J Am Coll Cardiol,1997,29(2):385

191 Savelieva I,Graydon R,Camm AJ.Pharmacological cardioversion of atrial fibrillation with vernakalant:evidence in support of the ESC Guidelines[J].Europace,2014,16(2):162

192 Reisinger J,Gatterer E,Heinze G,et al.Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation[J].Am J Cardiol,1998,81(12):1 450

193 Khan IA.Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation[J].Int J Cardiol,2003,87(2-3):121

194 Alboni P,Botto GL,Baldi N,et al.Outpatient treatment of recentonset atrial fibrillation with the"pill-in-the-pocket"approach[J].N Engl J Med,2004,351(23):2 384

195 Zhang N,Guo JH,Zhang H,et al.Comparison of intravenous ibutilide vs.propafenone for rapid termination of recent onset atrial fibrillation[J].Int J Clin Pract,2005,59(12):1 395

196 Khan IA.Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation[J].J Am Coll Cardiol,2001,37(2):542

197 Murray KT.Ibutilide[J].Circulation,1998,97(5):493

198 Patsilinakos S,Christou A,Kafkas N,et al.Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent[J].Am J Cardiol,2010,106(5):673

199 Kowey PR,Dorian P,Mitchell LB,et al.Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery:a randomized,double-blind,placebo-controlled trial[J].Circ Arrhythm Electrophysiol,2009,2(6):652

200 Camm AJ,Capucci A,Hohnloser SH,et al.A randomized activecontrolled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation[J].J Am Coll Cardiol,2011,57(3):313

201 Stiell IG,Roos JS,Kavanagh KM,et al.A multicenter,open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm[J].Am Heart J,2010,159(6):1 095

202 Pedersen OD,Bagger H,Keller N,et al.Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function:a Danish investigations of arrhythmia and mortality on dofetilide(diamond)substudy[J].Circulation,2001,104(3):292

203 刘文玲.注射用盐酸尼非卡兰临床应用中国专家共识[J].中国循环杂志,2017(01):8

204 Morita N,Tanaka K,Yodogawa K,et al.Effect of nifekalant for acute conversion of atrial flutter:the possible termination mechanism of typical atrial flutter[J].Pacing Clin Electrophysiol,2007,30(10):1 242

205 Okishige K,Uehara H,Miyagi N,et al.Clinical study of the acute effects of intravenous nifekalant on the defibrillation threshold in patients with persistent and paroxysmal atrial fibrillation[J].Circ J,2008,72(1):76

206 Saborido CM,Hockenhull J,Bagust A,et al.Systematic review and cost-effectiveness evaluation of'pill-in-the-pocket'strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy[J].Health Technol Assess,2010,14(31):1

207 Gallagher MM,Guo XH,P oloniecki JD,et al.Initial energy setting,outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter[J].J Am Coll Cardiol,2001,38(5):1 498

208 Oral H,Souza JJ,Michaud GF,et al.Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment[J].N Engl J Med,1999,340(24):1 849

209 Capucci A,Villani GQ,Aschieri D,et al.Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation[J].Eur Heart J,2000,21(1):66

210 Bianconi L,Mennuni M,Lukic V,et al.Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation:a placebo-controlled study[J].J Am Coll Cardiol,1996,28(3):700

211 Nergardh AK,Rosenqvist M,Nordlander R,et al.Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation:a randomized doubleblind placebo-controlled study[J].Eur Heart J,2007,28(11):1351

212 Hemels ME,Van Noord T,Crijns HJ,et al.Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation[J].J Am Coll Cardiol,2006,48(5):1 001

213 Villani GQ,Piepoli MF,Terracciano C,et al.Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation:a single-blind,randomized,controlled study[J].Am Heart J,2000,140(3):e12

214 The Digitalis in Acute Atrial Fibrillation(DAAF)Trial Group.Intravenous digoxin in acute atrial fibrillation.Results of a randomized,placebo-controlled multicentre trial in 239 patients[J].Eur Heart J,1997,18(4):649

215 Atarashi H,Inoue H,Fukunami M,et al.Double-blind placebocontrolled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation[J].Circ J,2002,66(6):553

216 Airaksinen KE,Gronberg T,Nuotio I,et al.Thromboembolic complications after cardioversion of acute atrial fibrillation:the Fin CV(Finnish Cardio Version)study[J].J Am Coll Cardiol,2013,62(13):1 187

217 Hansen ML,Jepsen RM,Olesen JB,et al.Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy[J].Europace,2015,17(1):18

218 Cappato R,Ezekowitz MD,Klein AL,et al.Rivaroxaban vs.vitamin K antagonists for cardioversion in atrial fibrillation[J].Eur Heart J,2014,35(47):3 346

219 Jaber WA,Prior DL,Thamilarasan M,et al.Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi:A transesophageal echocardiographic study[J].Am Heart J,2000,140(1):150

220 You JJ,Singer DE,Howard PA,et al.Antithrombotic therapy for atrial fibrillation:antithrombotic therapy and prevention of thrombosis,9th ed:American College of Chest Physicians EvidenceBased Clinical Practice Guidelines[J].Chest,2012,141(2 Suppl):e531S

221 Nagarakanti R,Ezekowitz MD,Oldgren J,et al.Dabigatran versus warfarin in patients with atrial fibrillation:an analysis of patients undergoing cardioversion[J].Circulation,2011,123(2):131

222 Flaker G,Lopes RD,Al-Khatib SM,et al.Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation:insights from the ARISTOTLE Trial(Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)[J].J Am Coll Cardiol,2014,63(11):1 082

223 Piccini JP,Stevens SR,Lokhnygina Y,et al.Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial[J].J Am Coll Cardiol,2013,61(19):1 998

224 Kaab S,Hinterseer M,Nabauer M,et al.Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QTsyndrome--a case-control pilot study using i.v.sotalol[J].Eur Heart J,2003,24(7):649

225 Fabritz L,Kirchhof P.Predictable and less predictable unwanted cardiac drugs effects:individual pre-disposition and transient precipitating factors[J].Basic Clin Pharmacol Toxicol,2010,106(3):263

226 Choy AM,Darbar D,Dell'Orto S,et al.Exaggerated QT prolongation after cardioversion of atrial fibrillation[J].J Am Coll Cardiol,1999,34(2):396

227 Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J].Europace,2010,12(10):1 360

228 Piccini JP,Hasselblad V,Peterson ED,et al.Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation[J].J Am Coll Cardiol,2009,54(12):1 089

229 AFFIRM First Antiarrhythmia Drug Substudy Investigators.Maintenance of sinus rhythm in patients with atrial fibrillation:an AFFIRM substudy of the first antiarrhythmic drug[J].J Am Coll Cardiol,2003,42(1):20

230 Cardiac Arrhythmia Suppression Trial(CAST)Investigators.Preliminary report:effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction[J].N Engl J Med,1989,321(6):406

231 Pritchett EL,Page RL,Carlson M,et al.Efficacy and safety of sustained-release propafenone(propafenone SR)for patients with atrial fibrillation[J].Am J Cardiol,2003,92(8):941

232 Hohnloser SH,Crijns HJ,van Eickels M,et al.Effect of dronedarone on cardiovascular events in atrial fibrillation[J].N Engl J Med,2009,360(7):668

233 Connolly SJ,Camm AJ,Halperin JL,et al.Dronedarone in highrisk permanent atrial fibrillation[J].N Engl J Med,2011,365(24):2 268

234 Davy JM,Herold M,Hoglund C,et al.Dronedarone for the control of ventricular rate in permanent atrial fibrillation:the Efficacy and safety of dRoned Arone for the c Ontrol of ventricular rate during atrial fibrillation(ERATO)study[J].Am Heart J,2008,156(3):521

235 Wang AH,Pu JL,Qi XY,et al.Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation:a randomized,double-blind and controlled multicenter trial.[J].Zhonghua Yi Xue Za Zhi,2011,91(24):1 677

236 Chen Y,Nie S,Gao H,et al.The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation:a meta-analysis of randomized controlled trials[J].Evid Based Complement Alternat Med,2013,2013:245 958

237 Schneider MP,Hua TA,Bohm M,et al.Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis[J].J Am Coll Cardiol,2010,55(21):2 299

238 Wachtell K,Lehto M,Gerdts E,et al.AngiotensinⅡreceptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol:the Losartan Intervention For End Point Reduction in Hypertension(LIFE)study[J].J Am Coll Cardiol,2005,45(5):712

239 Okin PM,Wachtell K,Devereux RB,et al.Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension[J].JAMA,2006,296(10):1 242

240 Savelieva I,Kakouros N,Kourliouros A,et al.Upstream therapies for management of atrial fibrillation:review of clinical evidence and implications for European Society of Cardiology guidelines.PartⅡ:secondary prevention[J].Europace,2011,13(5):610

241 Plewan A,Lehmann G,Ndrepepa G,et al.Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation;sotalol vs bisoprolol[J].Eur Heart J,2001,22(16):1 504

242 Liakopoulos OJ,Kuhn EW,Slottosch I,et al.Preoperative statin therapy for patients undergoing cardiac surgery[J].Cochrane Database Syst Rev,2012(4):D8493

243 Kuhn EW,Liakopoulos OJ,Stange S,et al.Preoperative statin therapy in cardiac surgery:a meta-analysis of 90,000 patients[J].Eur J Cardiothorac Surg,2014,45(1):17

244 Zheng Z,Jayaram R,Jiang L,et al.Perioperative Rosuvastatin in Cardiac Surgery[J].N Engl J Med,2016,374(18):1 744

245 Mansour M,Heist EK,Agarwal R,et al.Stroke and cardiovascular events after ablation or antiarrhythmic drugs for treatment of patients with atrial fibrillation[J].Am J Cardiol,2018,121(10):1192

246 Callans DJ.Apples and oranges:comparing antiarrhythmic drugs and catheter ablation for treatment of atrial fibrillation[J].Circulation,2008,118(24):2 488

247 Jais P,Cauchemez B,Macle L,et al.Catheter ablation versus antiarrhythmic drugs for atrial fibrillation:the A4 study[J].Circulation,2008,118(24):2 498

248 Oral H,Pappone C,Chugh A,et al.Circumferential pulmonaryvein ablation for chronic atrial fibrillation[J].N Engl J Med,2006,354(9):934

249 Pappone C,Augello G,Sala S,et al.A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation:the APAF Study[J].J Am Coll Cardiol,2006,48(11):2 340

250 Stabile G,Bertaglia E,Senatore G,et al.Catheter ablation treatment in patients with drug-refractory atrial fibrillation:a prospective,multi-centre,randomized,controlled study(Catheter Ablation For The Cure Of Atrial Fibrillation Study)[J].Eur Heart J,2006,27(2):216

251 Wazni OM,Marrouche NF,Martin DO,et al.Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation:a randomized trial[J].JAMA,2005,293(21):2 634

252 Wilber DJ,Pappone C,Neuzil P,et al.Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation:a randomized controlled trial[J].JAMA,2010,303(4):333

253 Kuck KH,Brugada J,Furnkranz A,et al.Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation[J].N Engl J Med,2016,374(23):2 235

254 Kuck KH,Furnkranz A,Chun KR,et al.Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation:reintervention,rehospitalization,and quality-of-life outcomes in the FIRE AND ICE trial[J].Eur Heart J,2016,37(38):2 858

255 Piccini JP,Lopes RD,Kong MH,et al.Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation:a meta-analysis of randomized,controlled trials[J].Circ Arrhythm Electrophysiol,2009,2(6):626

256 Cosedis NJ,Johannessen A,Raatikainen P,et al.Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation[J].N Engl J Med,2012,367(17):1 587

257 Morillo CA,Verma A,Connolly SJ,et al.Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation(RAAFT-2):a randomized trial[J].JAMA,2014,311(7):692

258 Hakalahti A,Biancari F,Nielsen JC,et al.Radiofrequency ablation vs.antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation:systematic review and meta-analysis[J].Europace,2015,17(3):370

259 Mont L,Bisbal F,Hernandez-Madrid A,et al.Catheter ablation vs.antiarrhythmic drug treatment of persistent atrial fibrillation:a multicentre,randomized,controlled trial(SARA study)[J].Eur Heart J,2014,35(8):501

260 Parkash R,Tang AS,Sapp JL,et al.Approach to the catheter ablation technique of paroxysmal and persistent atrial fibrillation:a meta-analysis of the randomized controlled trials[J].J Cardiovasc Electrophysiol,2011,22(7):729

261 Earley MJ,Abrams DJ,Staniforth AD,et al.Catheter ablation of permanent atrial fibrillation:medium term results[J].Heart,2006,92(2):233

262 Haissaguerre M,Jais P,Shah DC,et al.Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers[J].J Cardiovasc Electrophysiol,2000,11(1):2

263 Haissaguerre M,Hocini M,Sanders P,et al.Catheter ablation of long-lasting persistent atrial fibrillation:clinical outcome and mechanisms of subsequent arrhythmias[J].J Cardiovasc Electrophysiol,2005,16(11):1 138

264 Oral H,Chugh A,Good E,et al.Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms[J].Circulation,2007,115(20):2 606

265 Pappone C,Oreto G,Rosanio S,et al.Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation:efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation[J].Circulation,2001,104(21):2 539

266 Sanders P,Hocini M,Jais P,et al.Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation.Long-term clinical outcome[J].Eur Heart J,2007,28(15):1 862

267 Marrouche NF,Brachmann J,Andresen D,et al.Catheter Ablation for Atrial Fibrillation with Heart Failure[J].N Engl J Med,2018,378(5):417

268 Chen MS,Marrouche NF,Khaykin Y,et al.Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function[J].J Am Coll Cardiol,2004,43(6):1 004

269 Hsu L F,Jais P,Sanders P,et al.Catheter ablation for atrial fibrillation in congestive heart failure[J].N Engl J Med,2004,351(23):2 373

270 Khaykin Y,Marrouche NF,Saliba W,et al.Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery[J].Heart Rhythm,2004,1(1):33

271 Lang CC,Santinelli V,Augello G,et al.Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria:safety,feasibility,and efficacy[J].J Am Coll Cardiol,2005,45(6):868

272 Nedios S,Sommer P,Dagres N,et al.Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function:the importance of rhythm and rate control[J].Heart Rhythm,2014,11(3):344

273 Wang X,Liu X,Shi H,et al.Heart rhythm disorders and pacemakers:P ulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in patients with valvular heart diseases[J].Heart,2009,95(21):1773

274 Khan MN,Jais P,Cummings J,et al.Pulmonary-vein isolation for atrial fibrillation in patients with heart failure[J].N Engl J Med,2008,359(17):1 778

275 Andrade JG,Dubuc M,Guerra PG,et al.The biophysics and biomechanics of cryoballoon ablation[J].Pacing Clin Electrophysiol,2012,35(9):1 162

276 Packer DL,Kowal RC,Wheelan KR,et al.Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation:first results of the North American Arctic Front(STOP AF)pivotal trial[J].J Am Coll Cardiol,2013,61(16):1 713

277 Straube F,Dorwarth U,Vogt J,et al.Differences of two cryoballoon generations:insights from the prospective multicentre,multinational FREEZE Cohort Substudy[J].Europace,2014,16(10):1 434

278 Su W,Kowal R,Kowalski M,et al.Best practice guide for cryoballoon ablation in atrial fibrillation:The compilation experience of more than 3000 procedures[J].Heart Rhythm,2015,12(7):1658

279 Neven K,Schmidt B,Metzner A,et al.Fatal end of a safety algorithm for pulmonary vein isolation with use of high-intensity focused ultrasound[J].Circ Arrhythm Electrophysiol,2010,3(3):260

280 Dukkipati SR,Cuoco F,Kutinsky I,et al.Pulmonary Vein Isolation Using the Visually Guided Laser Balloon:A Prospective,Multicenter,and Randomized Comparison to Standard Radiofrequency Ablation[J].J Am Coll Cardiol,2015,66(12):1 350

281 Bordignon S,Chun KR,Gunawardene M,et al.Comparison of balloon catheter ablation technologies for pulmonary vein isolation:the laser versus cryo study[J].J Cardiovasc Electrophysiol,2013,24(9):987

282 Ouyang F,Bansch D,Ernst S,et al.Complete isolation of left atrium surrounding the pulmonary veins:new insights from the doubleLasso technique in paroxysmal atrial fibrillation[J].Circulation,2004,110(15):2 090

283 Augello G,Vicedomini G,Saviano M,et al.Pulmonary vein isolation after circumferential pulmonary vein ablation:comparison between Lasso and three-dimensional electroanatomical assessment of complete electrical disconnection[J].Heart Rhythm,2009,6(12):1 706

284 Marrouche NF,Martin DO,Wazni O,et al.Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation:impact on outcome and complications[J].Circulation,2003,107(21):2 710

285 Earley MJ,Showkathali R,Alzetani M,et al.Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location:a prospective randomized trial[J].Eur Heart J,2006,27(10):1223

286 Proietti R,Santangeli P,Di Biase L,et al.Comparative effectiveness of wide antral versus ostial pulmonary vein isolation:a systematic review and meta-analysis[J].Circ Arrhythm Electrophysiol,2014,7(1):39

287 Neuzil P,Reddy V Y,Kautzner J,et al.Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment:results from the EFFICAS I study[J].Circ Arrhythm Electrophysiol,2013,6(2):327

288 Nakamura K,Naito S,Kaseno K,et al.Optimal observation time after completion of circumferential pulmonary vein isolation for atrial fibrillation to prevent chronic pulmonary vein reconnections[J].Int J Cardiol,2013,168(6):5 300

289 Weerasooriya R,Jais P,Le Heuzey J Y,et al.Cost analysis of catheter ablation for paroxysmal atrial fibrillation[J].Pacing Clin Electrophysiol,2003,26(1 Pt 2):292

290 Vijayaraman P,Dandamudi G,Naperkowski A,et al.Assessment of exit block following pulmonary vein isolation:far-field capture masquerading as entrance without exit block[J].Heart Rhythm,2012,9(10):1 653

291 Steven D,Reddy VY,Inada K,et al.Loss of pace capture on the ablation line:a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation[J].Heart Rhythm,2010,7(3):323

292 Patel NJ,Deshmukh A,Pau D,et al.Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States:Analysis of 89,638 procedures[J].Heart Rhythm,2016,13(6):1 317

293 Wazni O,Marrouche NF,Martin DO,et al.Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation[J].Circulation,2003,108(20):2 479

294 Pappone C,Manguso F,Vicedomini G,et al.Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation:a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach[J].Circulation,2004,110(19):3 036

295 Lin WS,Tai CT,Hsieh MH,et al.Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy[J].Circulation,2003,107(25):3 176

296 Kumagai K.Catheter ablation of atrial fibrillation.-State of the Art[J].Circ J,2011,75(10):2 305

297 Kumagai K,Muraoka S,Mitsutake C,et al.A new approach for complete isolation of the posterior left atrium including pulmonary veins for atrial fibrillation[J].J Cardiovasc Electrophysiol,2007,18(10):1 047

298 Scherr D,Khairy P,Miyazaki S,et al.Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint[J].Circ Arrhythm Electrophysiol,2015,8(1):18

299 Verma A,Jiang CY,Betts TR,et al.Approaches to catheter ablation for persistent atrial fibrillation[J].N Engl J Med,2015,372(19):1 812

300 Vogler J,Willems S,Sultan A,et al.Pulmonary Vein Isolation Versus Defragmentation:The CHASE-AF Clinical Trial[J].J Am Coll Cardiol,2015,66(24):2 743

301 Kim TH,Park J,Park JK,et al.Linear ablation in addition to circumferential pulmonary vein isolation(Dallas lesion set)does not improve clinical outcome in patients with paroxysmal atrial fibrillation:a prospective randomized study[J].Europace,2015,17(3):388

302 Wynn GJ,Panikker S,Morgan M,et al.Biatrial linear ablation in sustained nonpermanent AF:Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation(SMAN-PAF)trial[J].Heart Rhythm,2016,13(2):399

303 Sawhney N,Anousheh R,Chen W,et al.Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation[J].Circ Arrhythm Electrophysiol,2010,3(3):243

304 Santangeli P,Zado ES,Hutchinson MD,et al.Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation[J].Heart Rhythm,2016,13(2):374

305 Chen SA,Tai CT.Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci[J].J Cardiovasc Electrophysiol,2005,16(2):229

306 Lee SH,Tai CT,Hsieh MH,et al.Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation:implication for catheter ablation[J].J Am Coll Cardiol,2005,46(6):1054

307 Di Biase L,Burkhardt JD,Mohanty P,et al.Left atrial appendage:an underrecognized trigger site of atrial fibrillation[J].Circulation,2010,122(2):109

308 Dixit S,Marchlinski FE,Lin D,et al.Randomized ablation strategies for the treatment of persistent atrial fibrillation:RASTA study[J].Circ Arrhythm Electrophysiol,2012,5(2):287

309 Kottkamp H.Human atrial fibrillation substrate:towards a specific fibrotic atrial cardiomyopathy[J].Eur Heart J,2013,34(35):2731

310 Verma A,Wazni OM,Marrouche NF,et al.Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation:an independent predictor of procedural failure[J].J Am Coll Cardiol,2005,45(2):285

311 Bai R,Di Biase L,Mohanty P,et al.Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation[J].Heart Rhythm,2016,13(1):132

312 Yang G,Yang B,Wei Y,et al.Catheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided substrate modification during sinus rhythm after pulmonary vein isolation[J].Circ Arrhythm Electrophysiol,2016,9(2):e3382

313 Oakes RS,Badger TJ,Kholmovski EG,et al.Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation[J].Circulation,2009,119(13):1 758

314 Mcgann C,Akoum N,Patel A,et al.Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI[J].Circ Arrhythm Electrophysiol,2014,7(1):23

315 Yang B,Jiang C,Lin Y,et al.STABLE-SR(Electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm)for the Treatment of Nonparoxysmal Atrial Fibrillation:A Prospective,Multicenter Randomized Clinical Trial[J].Circ Arrhythm Electrophysiol,2017,10(11)

316 Kottkamp H,Bender R,Berg J.Catheter ablation of atrial fibrillation:how to modify the substrate[J]?J Am Coll Cardiol,2015,65(2):196

317 Kottkamp H,Berg J,Bender R,et al.Box isolation of fibrotic areas(BIFA):a patient-tailored substrate modification approach for ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2016,27(1):22

318 Linz D,Schotten U,Neuberger HR,et al.Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation[J].Heart Rhythm,2011,8(9):1 436

319 Wang X,Huang C,Zhao Q,et al.Effect of renal sympathetic denervation on the progression of paroxysmal atrial fibrillation in canines with long-term intermittent atrial pacing[J].Europace,2015,17(4):647

320 Pokushalov E,Romanov A,Katritsis D G,et al.Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension:early experience[J].Heart Rhythm,2014,11(7):1 131

321 Schlaich MP,Socratous F,Hennebry S,et al.Sympathetic activation in chronic renal failure[J].J Am Soc Nephrol,2009,20(5):933

322 Bakris GL,Townsend RR,Flack JM,et al.12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension:the SYMPLICITY HTN-3 trial[J].J Am Coll Cardiol,2015,65(13):1 314

323 Nademanee K,Mckenzie J,Kosar E,et al.A new approach for catheter ablation of atrial fibrillation:mapping of the electrophysiologic substrate[J].J Am Coll Cardiol,2004,43(11):2 044

324 Lin YJ,Tai CT,Kao T,et al.Electrophysiological characteristics and catheter ablation in patients with paroxysmal right atrial fibrillation[J].Circulation,2005,112(12):1 692

325 Hansen BJ,Zhao J,Csepe T A,et al.Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous subepicardial and sub-endocardial optical mapping in explanted human hearts[J].Eur Heart J,2015,36(35):2 390

326 Gianni C,Mohanty S,Di Biase L,et al.Acute and early outcomes of focal impulse and rotor modulation(FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation[J].Heart Rhythm,2016,13(4):830

327 Buch E,Share M,Tung R,et al.Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation:A multicenter experience[J].Heart Rhythm,2016,13(3):636

328 Mikhaylov E,Kanidieva A,Sviridova N,et al.Outcome of anatomic ganglionated plexi ablation to treat paroxysmal atrial fibrillation:a 3-year follow-up study[J].Europace,2011,13(3):362

329 Pokushalov E,Romanov A,Artyomenko S,et al.Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation[J].Pacing Clin Electrophysiol,2010,33(10):1 231

330 Stavrakis S,Nakagawa H,Po SS,et al.The role of the autonomic ganglia in atrial fibrillation[J].JACC Clin Electrophysiol,2015,1(1-2):1

331 Pokushalov E,Romanov A,Katritsis D G,et al.Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation:a randomized comparison[J].Heart Rhythm,2013,10(9):1280

332 Driessen A,Berger WR,Krul S,et al.Ganglion Plexus Ablation in Advanced Atrial Fibrillation:The AFACT Study[J].J Am Coll Cardiol,2016,68(11):1 155

333 Kapa S,Killu A,Deshmukh A,et al.Dose-dependent pulmonary vein reconnection in response to adenosine:relevance of atrioventricular block during infusion[J].J Interv Card Electrophysiol,2016,47(1):117

334 Deshmukh A,Patel NJ,Pant S,et al.In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010:analysis of 93 801 procedures[J].Circulation,2013,128(19):2 104

335 Verma A,Natale A.Should atrial fibrillation ablation be considered first-line therapy for some patients?Why atrial fibrillation ablation should be considered first-line therapy for some patients[J].Circulation,2005,112(8):1 214

336 Reddy VY,Dukkipati SR,Neuzil P,et al.Randomized,controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation:Results of the Tacti Cath Contact Force Ablation Catheter Study for Atrial Fibrillation(TOCCASTAR)Study[J].Circulation,2015,132(10):907

337 Natale A,Reddy VY,Monir G,et al.Paroxysmal AF catheter ablation with a contact force sensing catheter:results of the prospective,multicenter SMART-AF trial[J].J Am Coll Cardiol,2014,64(7):647

338 Kuwahara T,Takahashi A,Takahashi Y,et al.Clinical characteristics of massive air embolism complicating left atrial ablation of atrial fibrillation:lessons from five cases[J].Europace,2012,14(2):204

339 von Bary C,Weber S,Dornia C,et al.Evaluation of pulmonary vein stenosis after pulmonary vein isolation using a novel circular mapping and ablation catheter(PVAC)[J].Circ Arrhythm Electrophysiol,2011,4(5):630

340 Di Biase L,Fahmy TS,Wazni OM,et al.Pulmonary vein total occlusion following catheter ablation for atrial fibrillation:clinical implications after long-term follow-up[J].J Am Coll Cardiol,2006,48(12):2 493

341 Packer DL,Keelan P,Munger TM,et al.Clinical presentation,investigation,and management of pulmonary vein stenosis complicating ablation for atrial fibrillation[J].Circulation,2005,111(5):546

342 Gerstenfeld EP.New technologies for catheter ablation of atrial fibrillation[J].Curr Treat Options Cardiovasc Med,2011,13(5):393

343 Cappato R,Calkins H,Chen SA,et al.Updated worldwide survey on the methods,efficacy,and safety of catheter ablation for human atrial fibrillation[J].Circ Arrhythm Electrophysiol,2010,3(1):32

344 Ghia KK,Chugh A,Good E,et al.A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation[J].J Interv Card Electrophysiol,2009,24(1):33

345 John RM,Kapur S,Ellenbogen KA,et al.Atrioesophageal fistula formation with cryoballoon ablation is most commonly related to the left inferior pulmonary vein[J].Heart Rhythm,2017,14(2):184

346 Pappone C,Oral H,Santinelli V,et al.Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation[J].Circulation,2004,109(22):2 724

347 Metzner A,Rausch P,Lemes C,et al.The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon[J].J Cardiovasc Electrophysiol,2014,25(5):466

348 Ling TY,Jin Q,Pan WQ,et al.Cryoballoon ablation in Chinese patients with paroxysmal atrial fibrillation:1-year follow-up[J].Pacing Clin Electrophysiol,2017,40(10):1 067

349 Shah D,Dumonceau JM,Burri H,et al.Acute pyloric spasm and gastric hypomotility:an extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation[J].J Am Coll Cardiol,2005,46(2):327

350 Takahashi Y,Jais P,Hocini M,et al.Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation[J].J Cardiovasc Electrophysiol,2005,16(10):1 104

351 Tisi PV,Callam MJ.Treatment for femoral pseudoaneurysms[J].Cochrane Database Syst Rev,2009(2):D4981

352 Puwanant S,Varr BC,Shrestha K,et al.Role of the CHADS2score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation[J].J Am Coll Cardiol,2009,54(22):2 032

353 Scherr D,Dalal D,Chilukuri K,et al.Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2009,20(4):379

354 Dong J,Calkins H,Solomon SB,et al.Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations[J].Circulation,2006,113(2):186

355 喻荣辉,马长生,董建增,等.电解剖标测和磁共振影像融合技术指导导管消融心房颤动的有效性研究[J].中华心血管病杂志,2007(11):1 029

356 Wazni OM,Beheiry S,Fahmy T,et al.Atrial fibrillation ablation in patients with therapeutic international normalized ratio:comparison of strategies of anticoagulation management in the periprocedural period[J].Circulation,2 0 0 7,1 1 6(2 2):25 3 1

357 Di Biase L,Burkhardt JD,Santangeli P,et al.Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management:results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation(AF)Patients Undergoing Catheter Ablation(COMPARE)randomized trial[J].Circulation,2014,129(25):2 638

358 Calkins H,Gerstenfeld EP,Schilling R,et al.RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation:assessment of an uninterrupted periprocedural anticoagulation strategy[J].Am J Cardiol,2015,115(1):154

359 龙德勇,刘兴鹏,马长生,等.心房颤动射频消融术中应用丙泊酚深度镇静的临床观察[J].中华心律失常学杂志,2006(5):338

360 Sairaku A,Yoshida Y,Hirayama H,et al.Procedural sedation with dexmedetomidine during ablation of atrial fibrillation:a randomized controlled trial[J].Europace,2014,16(7):994

361 Kottkamp H,Hindricks G,Eitel C,et al.Deep sedation for catheter ablation of atrial fibrillation:a prospective study in 650 consecutive patients[J].J Cardiovasc Electrophysiol,2011,22(12):1339

362 Bubien RS,Fisher JD,Gentzel JA,et al.NASPE expert consensus document:use of i.v.(conscious)sedation/analgesia by nonanesthesia personnel in patients undergoing arrhythmia specific diagnostic,therapeutic,and surgical procedures[J].Pacing Clin Electrophysiol,1998,21(2):375

363 Briceno DF,Villablanca PA,Lupercio F,et al.Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation:metaanalysis and meta-regression[J].J Cardiovasc Electrophysiol,2016,27(6):683

364 Maleki K,Mohammadi R,Hart D,et al.Intracardiac ultrasound detection of thrombus on transseptal sheath:incidence,treatment,and prevention[J].J Cardiovasc Electrophysiol,2005,16(6):561

365 Ren JF,Marchlinski FE,Callans DJ.Left atrial thrombus associated with ablation for atrial fibrillation:identification with intracardiac echocardiography[J].J Am Coll Cardiol,2004,43(10):1 861

366 Wazni OM,Rossillo A,Marrouche NF,et al.Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation:impact of different anticoagulation regimens and importance of intracardiac echo imaging[J].J Cardiovasc Electrophysiol,2005,16(6):576

367 Kwak JJ,Pak HN,Jang JK,et al.Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2010,21(6):620

368 Gautam S,John RM,Stevenson WG,et al.Effect of therapeutic INR on activated clotting times,heparin dosage,and bleeding risk during ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2011,22(3):248

369 Lakkireddy D,Reddy YM,Di Biase L,et al.Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation:results from a multicenter prospective registry[J].J Am Coll Cardiol,2012,59(13):1 168

370 Bassiouny M,Saliba W,Rickard J,et al.Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation[J].Circ Arrhythm Electrophysiol,2013,6(3):460

371 Kim JS,She F,Jongnarangsin K,et al.Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation[J].Heart Rhythm,2013,10(4):483

372 Martinek M,Bencsik G,Aichinger J,et al.Esophageal damage during radiofrequency ablation of atrial fibrillation:impact of energy settings,lesion sets,and esophageal visualization[J].J Cardiovasc Electrophysiol,2009,20(7):726

373 Hindricks G,Piorkowski C,Tanner H,et al.Perception of atrial fibrillation before and after radiofrequency catheter ablation:relevance of asymptomatic arrhythmia recurrence[J].Circulation,2005,112(3):307

374 Klemm HU,Ventura R,Rostock T,et al.Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation[J].J Cardiovasc Electrophysiol,2006,17(2):146

375 Kottkamp H,Tanner H,Kobza R,et al.Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions:trigger elimination or substrate modification:early or delayed cure[J]?J Am Coll Cardiol,2004,44(4):869

376 Oral H,Veerareddy S,Good E,et al.Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation[J].J Cardiovasc Electrophysiol,2004,15(8):920

377 Pokushalov E,Romanov A,Corbucci G,et al.Ablation of paroxysmal and persistent atrial fibrillation:1-year follow-up through continuous subcutaneous monitoring[J].J Cardiovasc Electrophysiol,2011,22(4):369

378 Senatore G,Stabile G,Bertaglia E,et al.Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation[J].J Am Coll Cardiol,2005,45(6):873

379 Vasamreddy CR,Dalal D,Dong J,et al.Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation[J].J Cardiovasc Electrophysiol,2006,17(2):134

380 Purerfellner H,Gillis AM,Holbrook R,et al.Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies[J].Pacing Clin Electrophysiol,2004,27(7):983

381 Seidl K,Meisel E,Vanagt E,et al.Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias[J]?Pacing Clin Electrophysiol,1998,21(4 Pt1):694

382 Eitel C,Husser D,Hindricks G,et al.Performance of an implantable automatic atrial fibrillation detection device:impact of software adjustments and relevance of manual episode analysis[J].Europace,2011,13(4):480

383 Hindricks G,Pokushalov E,Urban L,et al.Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation:Results of the XPECT trial[J].Circ Arrhythm Electrophysiol,2010,3(2):141

384 Oral H,Knight BP,Ozaydin M,et al.Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation[J].J Am Coll Cardiol,2002,40(1):100

385 Leong-Sit P,Roux JF,Zado E,et al.Antiarrhythmics after ablation of atrial fibrillation(5A Study):six-month follow-up study[J].Circ Arrhythm Electrophysiol,2011,4(1):11

386 Chilukuri K,Dukes J,Dalal D,et al.Outcomes in patients requiring cardioversion following catheter ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2010,21(1):27

387 Bertaglia E,Stabile G,Senatore G,et al.Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation[J].Pacing Clin Electrophysiol,2005,28(5):366

388 Vasamreddy CR,Lickfett L,Jayam VK,et al.Predictors of recurrence following catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter[J].J Cardiovasc Electrophysiol,2004,15(6):692

389 Calkins H,Reynolds MR,Spector P,et al.Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation:two systematic literature reviews and meta-analyses[J].Circ Arrhythm Electrophysiol,2009,2(4):349

390 Ouyang F,Tilz R,Chun J,et al.Long-term results of catheter ablation in paroxysmal atrial fibrillation:lessons from a 5-year followup[J].Circulation,2010,122(23):2 368

391 Tzou WS,Marchlinski FE,Zado ES,et al.Long-term outcome after successful catheter ablation of atrial fibrillation[J].Circ Arrhythm Electrophysiol,2010,3(3):237

392 Weerasooriya R,Khairy P,Litalien J,et al.Catheter ablation for atrial fibrillation:are results maintained at 5 years of follow-up[J]?J Am Coll Cardiol,2011,57(2):160

393 Kim YR,Nam GB,Han S,et al.Effect of short-term steroid therapy on early recurrence during the blanking period after catheter ablation of atrial fibrillation[J].Circ Arrhythm Electrophysiol,2015,8(6):1 366

394 Koyama T,Tada H,Sekiguchi Y,et al.Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation:a randomized controlled trial[J].J Am Coll Cardiol,2010,56(18):1 463

395 Deftereos S,Giannopoulos G,Efremidis M,et al.Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation:mid-term efficacy and effect on quality of life[J].Heart Rhythm,2014,11(4):620

396 Deftereos S,Giannopoulos G,Kossyvakis C,et al.Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation:a randomized controlled study[J].J Am Coll Cardiol,2012,60(18):1 790

397 Cox JL.The surgical treatment of atrial fibrillation.IV.Surgical technique[J].J Thorac Cardiovasc Surg,1991,101(4):584

398 Cox JL,Schuessler RB,D'Agostino HJ,et al.The surgical treatment of atrial fibrillation.Ⅲ.Development of a definitive surgical procedure[J].J Thorac Cardiovasc Surg,1991,101(4):569

399 Robertson JO,Saint LL,Leidenfrost JE,et al.Illustrated techniques for performing the Cox-Maze IV procedure through a right mini-thoracotomy[J].Ann Cardiothorac Surg,2014,3(1):105

400 Ad N,Henry L,Hunt S,et al.Do we increase the operative risk by adding the Cox MazeⅢprocedure to aortic valve replacement and coronary artery bypass surgery[J]?J Thorac Cardiovasc Surg,2012,143(4):936

401 Prasad SM,Maniar HS,Camillo CJ,et al.The Cox mazeⅢprocedure for atrial fibrillation:long-term efficacy in patients undergoing lone versus concomitant procedures[J].J Thorac Cardiovasc Surg,2003,126(6):1 822

402 Bugge E,Nicholson IA,Thomas SP.Comparison of bipolar and unipolar radiofrequency ablation in an in vivo experimental model[J].Eur J Cardiothorac Surg,2005,28(1):76

403 Benussi S,Galanti A,Zerbi V,et al.Electrophysiologic efficacy of irrigated bipolar radiofrequency in the clinical setting[J].J Thorac Cardiovasc Surg,2010,139(5):1 131

404 Gaynor SL,Diodato MD,Prasad SM,et al.A prospective,singlecenter clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation[J].J Thorac Cardiovasc Surg,2004,128(4):535

405 Miyairi T,Miura S,Kigawa I,et al.Mid-term results of a closed biatrial procedure using bipolar radiofrequency ablation concomitantly performed with non-mitral cardiac operations[J].Interact Cardiovasc Thorac Surg,2009,9(2):169

406 Rahman NM,Chard RB,Thomas SP.Outcomes for surgical treatment of atrial fibrillation using cryoablation during concomitant cardiac procedures[J].Ann Thorac Surg,2010,90(5):1 523

407 Funatsu T,Kobayashi J,Nakajima H,et al.Long-term results and reliability of cryothermic ablation based maze procedure for atrial fibrillation concomitant with mitral valve surgery[J].Eur J Cardiothorac Surg,2009,36(2):267

408 Weimar T,Schena S,Bailey MS,et al.The cox-maze procedure for lone atrial fibrillation:a single-center experience over 2 decades[J].Circ Arrhythm Electrophysiol,2012,5(1):8

409 Cox JL.A brief overview of surgery for atrial fibrillation[J].Ann Cardiothorac Surg,2014,3(1):80

410 Ad N,Suri RM,Gammie JS,et al.Surgical ablation of atrial fibrillation trends and outcomes in North America[J].J Thorac Cardiovasc Surg,2012,144(5):1 051

411 Gammie JS,Haddad M,Milford-Beland S,et al.Atrial fibrillation correction surgery:lessons from the Society of Thoracic Surgeons National Cardiac Database[J].Ann Thorac Surg,2008,85(3):909

412艾克拜尔·安尼瓦尔,艾斯卡尔·沙比提,阿布都乃比·麦麦提艾力,等.心脏手术中左心耳闭合在预防术后心房颤动和脑血管意外中的作用[J].中华心律失常学杂志,2016(2):149

413 Louagie Y,Buche M,Eucher P,et al.Improved patient survival with concomitant Cox MazeⅢprocedure compared with heart surgery alone[J].Ann Thorac Surg,2009,87(2):440

414 Phan K,Xie A,La Meir M,et al.Surgical ablation for treatment of atrial fibrillation in cardiac surgery:a cumulative meta-analysis of randomised controlled trials[J].Heart,2014,100(9):722

415 Wolf RK,Schneeberger EW,Osterday R,et al.Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation[J].J Thorac Cardiovasc Surg,2005,130(3):797

416 Krul SP,Driessen AH,van Boven WJ,et al.Thoracoscopic videoassisted pulmonary vein antrum isolation,ganglionated plexus ablation,and periprocedural confirmation of ablation lesions:first results of a hybrid surgical-electrophysiological approach for atrial fibrillation[J].Circ Arrhythm Electrophysiol,2011,4(3):262

417 Edgerton JR,Brinkman WT,Weaver T,et al.Pulmonary vein isolation and autonomic denervation for the management of paroxysmal atrial fibrillation by a minimally invasive surgical approach[J].J Thorac Cardiovasc Surg,2010,140(4):823

418 Yilmaz A,Geuzebroek GS,Van P utte BP,et al.Completely thoracoscopic pulmonary vein isolation with ganglionic plexus ablation and left atrial appendage amputation for treatment of atrial fibrillation[J].Eur J Cardiothorac Surg,2010,38(3):356

419 Boersma LV,Castella M,van Boven W,et al.Atrial fibrillation catheter ablation versus surgical ablation treatment(FAST):a 2-center randomized clinical trial[J].Circulation,2012,125(1):23

420 Wang J,Li Y,Shi J,et al.Minimally invasive surgical versus catheter ablation for the long-lasting persistent atrial fibrillation[J].PLo S One,2011,6(7):e22122

421 Jiang YQ,Tian Y,Zeng LJ,et al.The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation:A meta-analysis[J].PLo S One,2018,13(1):e190 170

422 Mahapatra S,Lapar D J,Kamath S,et al.Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up[J].Ann Thorac Surg,2011,91(6):1 890

423 La Meir M,Gelsomino S,Luca F,et al.Minimally invasive surgical treatment of lone atrial fibrillation:early results of hybrid versus standard minimally invasive approach employing radiofrequency sources[J].Int J Cardiol,2013,167(4):1 469

424 Hoogsteen J,Schep G,Van Hemel NM,et al.Paroxysmal atrial fibrillation in male endurance athletes.A 9-year follow up[J].Europace,2004,6(3):222

425 Wyse DG.Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation[J].J Interv Card Electrophysiol,2009,25(1):25

426 Kusumoto F,Prussak K,Wiesinger M,et al.Radiofrequency catheter ablation of atrial fibrillation in older patients:outcomes andcomplications[J].J Interv Card Electrophysiol,2009,25(1):31

427 Tendera M,Wycisk A,Schneeweiss A,et al.Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy[J].Cardiology,1993,82(5):335

428 Chen MS,Mccarthy PM,Lever HM,et al.Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy[J].Am J Cardiol,2004,93(3):373

429 Pietersen AH,Andersen ED,Sandoe E.Atrial fibrillation in the Wolff-Parkinson-White syndrome[J].Am J Cardiol,1992,70(5):38A

430 Zardini M,Yee R,Thakur RK,et al.Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome:current perspectives[J].Pacing Clin Electrophysiol,1994,17(5 Pt 1):966

431 Blomstrom-Lundqvist C,Scheinman MM,Aliot EM,et al.ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)[J].Circulation,2003,108(15):1 871

432 Simonian SM,Lotfipour S,Wall C,et al.Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation[J].Intern Emerg Med,2010,5(5):421

433 Akhtar M,Gilbert CJ,Shenasa M.Effect of lidocaine on atrioventricular response via the accessory pathway in patients with WolffParkinson-White syndrome[J].Circulation,1981,63(2):435

434 Dolla E,Levy S,Cointe R,et al.Oral propranolol in Wolff-Parkinson-White syndrome.Electrophysiological data.[J].Arch Mal Coeur Vaiss,1991,84(7):917

435 Maisel WH,Stevenson LW.Atrial fibrillation in heart failure:epidemiology,pathophysiology,and rationale for therapy[J].Am J Cardiol,2003,91(6A):2D

436 Tsang TS,Gersh BJ,Appleton CP,et al.Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women[J].J Am Coll Cardiol,2002,40(9):1 636

437 夏文芳,于胜波,赵庆彦,等.心房颤动对慢性收缩性心力衰竭患者和射血分数正常心力衰竭患者预后的影响[J].中国心脏起搏与心电生理杂志,2014,28(05):423

438 Roy D,Talajic M,Nattel S,et al.Rhythm control versus rate control for atrial fibrillation and heart failure[J].N Engl J Med,2008,358(25):2 667

439 Bortone A,Pujadas-Berthault P,Karam N,et al.Catheter ablation in selected patients with depressed left ventricular ejection fraction and persistent atrial fibrillation unresponsive to current cardioversion[J].Europace,2013,15(11):1 574

440 Brignole M,Botto G,Mont L,et al.Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation:a randomized trial[J].Eur Heart J,2011,32(19):2 420

441 Upadhyay GA,Choudhry NK,Auricchio A,et al.Cardiac resynchronization in patients with atrial fibrillation:a meta-analysis of prospective cohort studies[J].J Am Coll Cardiol,2008,52(15):1239

442 Leong-Sit P,Zado E,Callans DJ,et al.Efficacy and risk of atrial fibrillation ablation before 45 years of age[J].Circ Arrhythm Electrophysiol,2010,3(5):452

443 Chun KR,Schmidt B,Kuck KH,et al.Catheter ablation of atrial fibrillation in the young:insights from the German Ablation Registry[J].Clin Res Cardiol,2013,102(6):459

444 El-Deeb MH,Sulaiman KJ,Al RA,et al.2014 Oman Heart Association protocol for the management of acute atrial fibrillation[J].Crit Pathw Cardiol,2014,13(3):117

445 Khoo CW,Lip G.Acute management of atrial fibrillation[J].Chest,2009,135(3):849

446 Atzema CL,Lam K,Young C,et al.Patients with atrial fibrillation and an alternative primary diagnosis in the emergency department:a description of their characteristics and outcomes[J].Acad Emerg Med,2013,20(2):193

447 Healey JS,Oldgren J,Ezekowitz M,et al.Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation:a cohort study[J].Lancet,2016,388(10050):1 161

448 Lopes RD,Pieper KS,Horton JR,et al.Short-and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation[J].Heart,2008,94(7):867

449 Echahidi N,Pibarot P,O'Hara G,et al.Mechanisms,prevention,and treatment of atrial fibrillation after cardiac surgery[J].J Am Coll Cardiol,2008,51(8):793

450 Amat-Santos IJ,Rodes-Cabau J,Urena M,et al.Incidence,predictive factors,and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation[J].J Am Coll Cardiol,2012,59(2):178

451 Carlson MD,Ip J,Messenger J,et al.A new pacemaker algorithm for the treatment of atrial fibrillation:results of the Atrial Dynamic Overdrive Pacing Trial(ADOPT)[J].J Am Coll Cardiol,2003,42(4):627

452 Purerfellner H,Ruiter JH,Widdershoven JW,et al.Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing(PMOP)algorithm[J].Heart Rhythm,2006,3(10):1 164

453 Camm AJ,Lip GY,De Caterina R,et al.2012 focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC Guidelines for the management of atrial fibrillation——developed with the special contribution of the European Heart Rhythm Association[J].Europace,2012,14(10):1385

454 Nuotio I,Hartikainen JE,Gronberg T,et al.Time to cardioversion for acute atrial fibrillation and thromboembolic complications[J].JAMA,2014,312(6):647

455 Hagens VE,Ranchor AV,Van Sonderen E,et al.Effect of rate or rhythm control on quality of life in persistent atrial fibrillation.Results from the Rate Control Versus Electrical Cardioversion(RACE)Study[J].J Am Coll Cardiol,2004,43(2):241

456 Piccini J P,Fauchier L.Rhythm control in atrial fibrillation[J].Lancet,2016,388(10046):829

457 Atzema CL,Austin PC.Rate control with beta-blockers versus calcium channel blockers in the emergency setting:predictors of medication class choice and associated hospitalization[J].Acad Emerg Med,2017,24(11):1 334

458 Stiell IG,Macle L.Canadian Cardiovascular Society atrial fibrillation guidelines 2010:management of recent-onset atrial fibrillation and flutter in the emergency department[J].Can J Cardiol,2011,27(1):38

459 Oral H,Ozaydin M,Sticherling C,et al.Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion[J].J Cardiovasc Electrophysiol,2003,14(2):182

460 Schwartzman D,Musley S,Koehler J,et al.Impact of atrial fibrillation duration on postcardioversion recurrence[J].Heart Rhythm,2005,2(12):1 324

461 Gronberg T,Hartikainen JE,Nuotio I,et al.Can we predict the failure of electrical cardioversion of acute atrial fibrillation?The Fin CV study[J].Pacing Clin Electrophysiol,2015,38(3):368

462 Pina PG,Chicos AB.Early cardioversion in atrial fibrillation:earlier is better,but not always and(Maybe)not immediately[J].Curr Atheroscler Rep,2017,19(1):3

463 Stiell IG,Clement CM,Perry JJ,et al.Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter[J].CJEM,2010,12(3):181

464 Burton JH,Vinson DR,Drummond K,et al.Electrical cardioversion of emergency department patients with atrial fibrillation[J].Ann Emerg Med,2004,44(1):20

465 Stiell IG,Clement CM,Brison RJ,et al.Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments[J].Ann Emerg Med,2011,57(1):13

466 Fernando HC,Jaklitsch MT,Walsh GL,et al.The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery:executive summary[J].Ann Thorac Surg,2011,92(3):1 144

467 Kinst TF,Sweeney MO,Lehr JL,et al.Simulated internal defibrillation in humans using an anatomically realistic three-dimensional finite element model of the thorax[J].J Cardiovasc Electrophysiol,1997,8(5):537

468 Pagan-Carlo LA,Spencer KT,Robertson CE,et al.Transthoracic defibrillation:importance of avoiding electrode placement directly on the female breast[J].J Am Coll Cardiol,1996,27(2):449

469 Hobbs WJ,Fynn S,Todd DM,et al.Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans[J].Circulation,2000,101(10):1 145

470 Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006guidelines for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation):developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Circulation,2006,114(7):e257

471 Kirchhof P,Eckardt L,Loh P,et al.Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation:a randomised trial[J].Lancet,2002,360(9342):1275

472 Atzema CL,Singh SM.Acute management of atrial fibrillation:from emergency department to cardiac care unit[J].Cardiol Clin,2018,36(1):141

473 Long B,Robertson J,Koyfman A,et al.Emergency medicine considerations in atrial fibrillation[J].Am J Emerg Med,2018,36(6):1 070

474 Purerfellner H,Ruiter JH,Widdershoven JW,et al.Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing(PMOP)algorithm[J].Heart Rhythm,2006,3(10):1 164

475 Sulke N,Silberbauer J,Boodhoo L,et al.The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation:the Pacemaker Atrial Fibrillation Suppression(PAFS)study[J].Europace,2007,9(9):790

476 Epstein AE,Dimarco JP,Ellenbogen KA,et al.ACC/AHA/HRS2008 Guidelines for device-based therapy of cardiac rhythm abnormalities[J].Heart Rhythm,2008,5(6):e1

477 Gold MR,Adler S,Fauchier L,et al.Impact of atrial prevention pacing on atrial fibrillation burden:primary results of the Study of Atrial Fibrillation Reduction(SAFARI)trial[J].Heart Rhythm,2009,6(3):295

478 Padeletti L,Purerfellner H,Mont L,et al.New-generation atrial antitachycardia pacing(Reactive ATP)is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia:Results from the MINERVA randomized multicenter international trial[J].Heart Rhythm,2015,12(8):1 717

479 Connolly SJ,Kerr CR,Gent M,et al.Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes.Canadian Trial of Physiologic Pacing Investigators[J].N Engl J Med,2000,342(19):1 385

480 Lamas GA,Lee KL,Sweeney MO,et al.Ventricular pacing or dual-chamber pacing for sinus-node dysfunction[J].N Engl J Med,2002,346(24):1 854

481 Toff WD,Camm AJ,Skehan JD.Single-chamber versus dualchamber pacing for high-grade atrioventricular block[J].N Engl J Med,2005,353(2):145

482 Healey JS,Toff WD,Lamas GA,et al.Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing:meta-analysis of randomized trials,using individual patient data[J].Circulation,2006,114(1):11

483 Sweeney MO,Hellkamp AS,Ellenbogen KA,et al.Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction[J].Circulation,2003,107(23):2 932

484 Sweeney MO,Bank AJ,Nsah E,et al.Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease[J].N Engl J Med,2007,357(10):1 000

485 Leclercq C,Walker S,Linde C,et al.Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation[J].Eur Heart J,2002,23(22):1 780

486 Gasparini M,Auricchio A,Metra M,et al.Long-term survival in patients undergoing cardiac resynchronization therapy:the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation[J].Eur Heart J,2008,29(13):1 644

487 Ponikowski P,Voors AA,Anker SD,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC).Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur J Heart Fail,2016,18(8):891

488 Kirchhof P,Calkins H.Catheter ablation in patients with persistent atrial fibrillation[J].Eur Heart J,2017,38(1):20

489 Boersma LV,Ince H,Kische S,et al.Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation:1-Year follow-up outcome data of the EWOLUTION trial[J].Heart Rhythm,2017,14(9):1 302

490 Kuramatsu JB,Gerner ST,Schellinger PD,et al.Anticoagulant reversal,blood pressure levels,and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage[J].JAMA,2015,313(8):824

491 van Nieuwenhuizen KM,van der Worp HB,Algra A,et al.Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intra Cerebral Ha Emorrhage in patients with Atrial Fibrillation(APACHE-AF):study protocol for a randomised controlled trial[J].Trials,2015,16:393

492 Gronberg T,Nuotio I,Nikkinen M,et al.Arrhythmic complications after electrical cardioversion of acute atrial fibrillation:the Fin CV study[J].Europace,2013,15(10):1 432

493 Philippart R,Brunet-Bernard A,Clementy N,et al.Prognostic value of CHA2DS2-VASc score in patients with'non-valvular atrial fibrillation'and valvular heart disease:the Loire Valley Atrial Fibrillation Project[J].Eur Heart J,2015,36(28):1 822

494 Fabritz L,Guasch E,Antoniades C,et al.Expert consensus document:Defining the major health modifiers causing atrial fibrillation:a roadmap to underpin personalized prevention and treatment[J].Nat Rev Cardiol,2016,13(4):230

495 Taylor DW,Barnett HJ,Haynes RB,et al.Low-dose and highdose acetylsalicylic acid for patients undergoing carotid endarterectomy:a randomised controlled trial.ASA and Carotid Endarterectomy(ACE)Trial Collaborators[J].Lancet,1999,353(9171):2179

496 Watanabe M,Chaudhry SA,Adil MM,et al.The effect of atrial fibrillation on outcomes in patients undergoing carotid endarterectomy or stent placement in general practice[J].J Vasc Surg,2015,61(4):927